0.9% SODIUM CHLORIDE INJECTION USP 9 MG
SODIUM CHLORIDE : 9 MG · DIN 02304341 · HIKMA CANADA LIMITED
Health Canada status: MARKETED
What is 0.9% SODIUM CHLORIDE INJECTION USP?
0.9% SODIUM CHLORIDE INJECTION USP 9 MG contains SODIUM CHLORIDE : 9 MG. It is listed in the Health Canada Drug Product Database under DIN 02304341, held by HIKMA CANADA LIMITED, supplied as SOLUTION for SUBCUTANEOUS ; INTRAMUSCULAR ; INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 09-May-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is 0.9% SODIUM CHLORIDE INJECTION USP used for?
Source of water and electrolytes; vehicle or diluent for compatible parenteral products; priming solution in hemodialysis procedures.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02304341 |
|---|---|
| Brand name | 0.9% SODIUM CHLORIDE INJECTION USP |
| Generic / active ingredient | SODIUM CHLORIDE : 9 MG |
| Manufacturer | HIKMA CANADA LIMITED |
| Strength | 9 MG |
| Dosage form | SOLUTION |
| Route of administration | SUBCUTANEOUS ; INTRAMUSCULAR ; INTRAVENOUS |
| Schedule | Ethical |
| ATC code | V07AB SOLVENTS AND DILUTING AGENTS, INCL IRRIGAT SOLUT |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 09-May-2024 |
How is it administered?
Individualized by physician based on age, weight, and clinical condition. Administered intravenously using sterile equipment. Inspect for particulates; do not store solutions with additives.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at 15°C to 30°C. Avoid excessive heat.
How is it supplied?
Available in 10 mL plastic ampoules.
Contraindications
Hypersensitivity to this drug or to any ingredient in the formulation or component of the container.
Warnings and precautions
Risk of fluid/solute overload, electrolyte disturbances, and hyponatremia. Use with caution in patients with congestive heart failure, severe renal impairment, or edema with sodium retention.
What can be used instead?
Other Canadian products sharing ATC code V07AB SOLVENTS AND DILUTING AGENTS, INCL IRRIGAT SOLUT. 23 of 62 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP | 9 MG | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 00037818 |
| BACTERIOSTATIC WATER FOR INJECTION USP | 30 ML / 30 ML | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 00038202 |
| BACTERIOSTATIC WATER FOR INJECTION USP-PRE-FILLED SYRINGE | 99.1 % | LIQUID | PFIZER CANADA ULC | MARKETED | DIN 02215721 |
| BSS PLUS | 0.042 % | SOLUTION ; KIT | ALCON CANADA INC | MARKETED | DIN 00568082 |
| BSS STERILE IRRIGATING SOLUTION | 0.17 % | SOLUTION | ALCON CANADA INC | MARKETED | DIN 00512990 |
| GLYCERINATED PHENOL SALINE | 0.4 % | LIQUID | ALK-ABELLO INC | MARKETED | DIN 00298417 |
| PH 12 STERILE DILUENT FOR FLOLAN | 94 MG | LIQUID | GLAXOSMITHKLINE INC | MARKETED | DIN 02443651 |
| PHENOL SALINE INJ | 0.9 % | LIQUID | ALK-ABELLO INC | MARKETED | DIN 00298409 |
| SODIUM CHLORIDE BACTERIOSTATIC INJ | 9 MG | LIQUID | OMEGA LABORATORIES LIMITED | MARKETED | DIN 00402249 |
| SODIUM CHLORIDE INJECTION USP, 0.9% W/V | 9 MG | SOLUTION | STERINOVA INC. | MARKETED | DIN 02560100 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.